Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
Devonshire V, Havrdova E, Radue E W, O'Connor P, Zhang-Auberson L, Agoropoulou C, Häring D A, Francis G, Kappos L, for the FREEDOMS study group
